Search This Blog

Monday, April 29, 2019

NGM Biopharmaceuticals initiated at Citi

NGM Biopharmaceuticals initiated with a Buy at Citi. Citi analyst Joel Beatty started NGM Biopharmaceuticals with a Buy rating and $29 price target. Read more at: https://thefly.com/landingPageNews.php?id=2899009
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)